Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780662-25-000002

Chief Financial Officer sold 238 shares at $14.05 ($3,344)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Sale : show line 1 in the form −238 $14.05 $3,344 269,343 D
Open-market sales · 238 sh · avg $14.05 · $3,344
Loading xslF345X05/primary_doc.xml…